Clinical Trial Update: The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dual antiplatelet therapy in acute transient ischemic attack and minor stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minor Stroke
• Transient Ischemic Attack

Snippet

Sponsor: University of Alberta | Conditions: Transient Ischemic Attacks, Minor Stroke | Phase 4 | Status: WITHDRAWN